| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |